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Recurrent Multitask-Learning for Irregular Clinical Time Series Forecasting
Suraj Subramanian, M.S.
University of Pittsburgh, 2020
Inflammatory Bowel Disease (IBD) is a group of chronic gastrointestinal disorders that
are difficult to treat. Having no known cure, treatment courses can be long-term and ex-
pensive. IBD flare-ups can happen without warning and there exists no objective criteria to
measure the disease’s activity. Recently, Recurrent Neural Networks (RNN) have emerged as
a state-of-the-art method in clinical time series analysis; building on recent work that apply
RNNs to temporal patient data, this thesis explores methodologies for processing temporal
clinical data, the feasibility of a deep RNN classifier to forecast the future healthcare uti-
lization, and techniques to curb overfitting while training on a small dataset. This work
shows that multitask learning is helpful to train stable models, and deep networks can be
engineered to process small noisy datasets in the clinical domain.
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1.0 Introduction
Inflammatory Bowel Disease (IBD) is a group of chronic gastrointestinal disorders that
are difficult to treat. IBD is a chronic disease requiring long-term care; managing the disease
can be difficult owing to largely unpredictable responses to treatments. A characteristic of
the disease is a sudden re-occurrence of symptoms even after an extended period of remission,
known as flare-ups. Serious flare-ups may require complicated and intensive measures such
as surgically removing a part of the colon. A possibility of knowing in advance which patients
are likely to undergo such procedures can help care-providers design their treatment strategy.
With the advent of electronic health records and machine learning, there is a surging
interest to tackle these problems with predictive analytics. This thesis describes work done
in this direction as part of a larger effort at the IBD Translational Research Center at
UPMC. The primary aims of this work are to 1. Investigate the feasibility of using deep
neural networks on a small clinical dataset, and 2. Explore if the irregular occurrence of
medical events holds useful exploitable information. In this work, I apply techniques like
multitask learning and parameterizing missing variables to help the model overcome data
sparsity and approximate the distribution from lesser training examples. The results of this
research indicate the usefulness of these techniques to stably train a complex model on a
small dataset.
The rest of this thesis is structured as follows: Section 1 presents background information
on IBD, Clinical Decision Support Systems (CDSS), Neural Networks and Deep Learning,
EHR and EHR analytics, and current machine learning methods in IBD research. Section
2 talks about the prior work that this thesis builds upon. Section 3 contains a description
of the variables used to train the model. Section 4 details cross validation schemes for time
series, the architecture of the model, the experiment methodology, caveats and constraints
regarding validation integrity, and the results. Section 5 consists of the conclusion and future
recommendations in this line of research.
1
2.0 Background
2.1 Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is a class of chronic inflammatory disorders affecting
the gastrointestinal tract. The specific causes of IBD are not known, and it is believed to
result from genetic variations, environmental influences, alterations in gut flora and distur-
bances in the immune system responses (Abraham & Cho, 2009), (Jostins et al., 2012). IBD
and its major subgroups – Crohn’s Disease (CD) and Ulcerative Colitis (UC) – often ex-
hibit patterns of remissions and flare-ups; response to treatments is largely unpredictable. A
large number of IBD patients require hospitalization at some point in their lives, thus incur-
ring heavy financial burden (Cohen, Larson, Roth, Becker, & Mummert, 2000), (Silverstein
et al., 1999). Smaller groups of patients contribute disproportionately to overall expendi-
tures (Click, Binion, & Anderson, 2017). Prognosticating the disease course among patients
of IBD is difficult challenge because of varied responses to treatments. A standard strat-
egy is systematic incrementalism – a slow-and-steady method of treatment as opposed to
early intensive interventions like surgery. This can involve considerable trial-and-error before
triaging onto the treatment plan that works for a patient. IBD greatly affects well-being
and quality of life; two tools to measure disease severity are the Harvey-Bradshaw Index
(Vermeire, Schreiber, Sandborn, Dubois, & Rutgeerts, 2010) and the SIBDQ (Han et al.,
2000). One of their major shortcomings are they both are subjective measures and it is not
easy to standardize these scores across a population. This study uses healthcare utilization
charges as a proxy for how well or poorly a patient is doing.
2.2 Clinical Decision Support
The Office of the National Coordinator for Health Information Technology defines Clin-
ical Decision Support Systems (CDSS) as what “provides clinicians, staff, patients, or other
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individuals with knowledge and person-specific information, intelligently filtered or presented
at appropriate times, to enhance health and health care” (Osheroff et al., 2007). The evolu-
tion of CDSS has a trajectory similar to those of general decision support systems; classical
CDS includes alerts, reminders, facilitation of computerized physician order entry (CPOE),
and interactive dashboards analogous to many Business Intelligence (BI)/Analytics software.
Initial systems in the 1960s were powered by Bayesian statistics and decision trees, with a
pinch of early AI (Pople, Myers, & Miller, 1975). The underlying methods powering many
of today’s CDSSs have come a long way from manually encoding clinician expertise and
rules in knowledge bases. This is partly due to the proliferation of Electronic Health Record
interoperability, and inexpensive computational means necessary to process Big Data.
Bright et al. report that CDSS have a favorable effect on prescribing treatments, fa-
cilitating preventive care services, and ordering clinical studies across diverse venues and
systems. In published research, there appears to be considerable evidence of CDSS efficacy
in improving health care process measures, but sparse evidence with regards to predicting
clinical outcomes (Bright et al., 2012). This can be attributed to a lack of significant evidence
to the difficulty of evaluating CDSS in RCTs. A significant barrier to adoption of CDSS
is vetting the reliability of the system’s recommendations. Probabilistic inference is often
counterintuitive for humans and leads to physicians ignoring CDSS recommendations if they
have made their decision (Bates, 1998). Many of the underlying ML models are “black-box”
(i.e. lack interpretability). Experienced clinicians are likely to trust their judgements when
at odds with a CDSS, and novice practitioners are likely not confident enough to make such
an evaluation.
A majority of CDSS surveyed in Jaspers, Smeulers, Vermeulen, and Peute (2011) and
Bright et al. (2012) haven’t moved beyond the basic features of classical decision support.
As of 2009, only about 1.5% of 3000 surveyed hospitals report the use of “Comprehensive
EHR” (Jha et al., 2009). On the other hand, in clinical informatics research there is a
growing interest in using machine learning in a CDSS. A Google Scholar count of ”electronic
health record deep learning” evidences this (Fig. 1).
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Figure 1: Trend of research interest in EHR and DL
2.2.1 Deep Learning in CDSS
A proliferation of electronic medical data has led to a rapid rise (Fig. 1) in the use of
deep learning methods to analyze complex problems in healthcare. Some of the areas it has
had major impact in are clinical imaging, genomics and EHR analysis.In an excellent survey
of state-of-the-art applications of DL in healthcare, (Shickel, Tighe, Bihorac, & Rashidi,
2018) categorize current research in the field into 5 overarching tasks:
Information Extraction Parsing meaningful concepts from clinical notes, a difficult task
for traditional ML compounded by the unstructured nature of this data.
Representation Learning Static hierarchical ontologies are often inadequate to capture
complex interactions and subtle similarities often found among medical concepts. Repre-
sentation Learning projects these concepts into high-dimensional vector space to encode
natural relationships in an unsupervised manner.
Outcome Prediction An ultimate goal, the authors suggest two essential types of out-
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come prediction - static, where the prediction is not constrained to temporal horizons
(eg: single point identification of medical conditions), and temporal, where the model
either relies on time-series data, or makes a prediction for a specific time window.
Computational Phenotyping True to the spirit of ML, these studies allow the data to
speak for itself; unsupervised algorithms comb through large volumes of data to determine
clusters of phenotypes indicative of an outcome of interest.
Clinical Text De-identification The use of RNNs to automatically deidentify Personal
Health Information, to adhere to HIPAA guidelines.
Clinician notes are often unstructured, noisy and may contain non-standard medical jar-
gon, which pose a challenge to vanilla ML and NLP methods, but are suitable for DL. (Liu,
Ge, Mathews, Ji, & McGuinness, 2018) use word-embedding from CNNs to automatically
expand abbreviations in clinical ICU notes. (Jagannatha & Yu, 2016) use LSTM and GRU
to extract medical events from clinical notes. (Miotto, Li, Kidd, & Dudley, 2016) use de-
noising autoencoders (an unsupervised DL algorithm) to build representations of the patient
that encode latent patterns in their clinical events, and are predictive of diseases like dia-
betes and schizophrenia. (Lasko, Denny, & Levy, 2013) use unsupervised DL methods for
longitudinal clinical phenotype discovery from episodic EHR data. (Gulshan et al., 2016)
use Convolutional Neural Networks (CNN) to detect diabetic retinopathy from ophthalmic
imaging data with physician-like accuracy. (Lipton, Kale, Elkan, & Wetzel, 2015) trained a
LSTM-RNN to recognize diagnoses from the patient’s full time-series data. (Choi, Bahadori,
Schuetz, Stewart, & Sun, 2016) use a GRU-RNN trained on EHR to predict major clinical
events in the future.
Despite their successes, deep learning approaches to health data suffer from important
limitations, a prominent criticism is the lack of interpretability of the model’s predictions. In
clinical settings a degree of interpretability is necessary, especially when being used to guide
diagnoses and treatment decisions. Deep networks often require voluminous datasets; for less
common disorders like IBD, it can often take several years to collect enough data to train a
model. The quality of data directly influences the performance of a deep learning algorithm.
Medical records are especially prone to noise, ambiguity, sparsity and heterogeneity, making
it challenging to train a good model.
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2.3 Electronic Health Record
An Electronic Health Record (EHR) system is a repository of electronically maintained
information about an individual’s health status and care. An EHR represents the snapshot a
patient’s state in time. While it can be thought of as a digitized version of a patient’s paper
chart, the information collected can go beyond standard clinical data, offering a broader
view of the patient. A comprehensive EHR contains information about billings and claims,
patient demographics, medications, lab and test results, allergies, comorbidities and clinician
notes. EHRs are built to share information among healthcare providers - so they contain
information from all the clinicians involved in the patient’s care. At current rates of adoption,
even a small hospital would have millions of records over a decade - an aggregate equivalent
of centuries of doctor wisdom (Esteva et al., 2019).
2.3.1 EHR Analytics
Physicians often do not have the bandwidth to use every relevant prior medical record
for their diagnoses. Given the volume of available data, statistical and machine learning
models are better suited to uncover patterns in patient interactions and outcomes, predict
the possibility of important events (eg: hospitalization, drug prescriptions, ER surgery), and
estimate the efficacy of different treatment pathways.
A common use case for EHR Analytics is predictive risk assessment to improve patient
outcomes or reduce costs. For example, the current incidence of early-onset sepsis (EOS) is
0.05-0.1% of all live births, but antibiotics are administered to 11% of infants born. Kaiser
Permanente Northern California (an insurance company) used data mining and logistic re-
gression to develop a risk-stratification model of EOS in infants. The model was trained on
data points collected from the mothers’ and babies’ EHR (Escobar et al., 2013). The contin-
uous aggregation of data in the EHR facilitates comparative effectiveness research identifying
optimal interventions tailored to patient-level characteristics (Miriovsky, Shulman, & Aber-
nethy, 2012). Large volumes of EHR data fed into a common data model has been used
to predict the risk of heart failure, determine alternative medications and treatments, and
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identify at-risk patients from patterns in healthcare utilization (Gotz, Stavropoulos, Sun, &
Wang, 2012). Topic modelling and Natural Language Processing (NLP) analyses on inpatient
psychiatric discharge notes have been used to predict psychiatric readmissions (Rumshisky
et al., 2016). One group highlights the potential shortcomings of such approaches, namely
the exclusion of disadvantaged populations and a myopic focus on short-term optimizations
like cost instead of long-term health (Wharam & Weiner, 2012).
By its very nature, EHR data is challenging to analyze by automatic systems. EHR data
is noisy, heterogeneous, and sparse. Non-standard reporting of lab results across different
providers, missing values, and incorrect patient information can heavily skew the algorithm’s
decision. Furthermore, its asynchronous nature is reflected in the irregular frequency of mea-
surements among all features. A common approach to time-series dimensionality reduction
is to represent all the values of a variable within a time window by its mean, described as
Piecewise Aggregate Approximation (Lin, Keogh, Wei, & Lonardi, 2007). While this re-
duces the complexity of the problem space, there are several pieces of information lost in
this aggregation. Granular changes in values of lab or test results can be indicative of future
outcomes. In aggregating, not only do these values regress to the average (which might lead
to mispredictions) but any trends of change within the discrete time window is also lost.
Concurrent variations in the patients’ attributes that might have phenotypic importance are
diminished in aggregation.
2.4 Artificial Neural Networks
Artificial Neural Networks (ANN) are a class of Machine Learning (ML) algorithms that
attempt to emulate the human brain in function. Over the past decades, ANNs have been at
the heart of systems in myriad domains - financial analysis, petroleum exploration, missile
guidance systems, and famously, early autonomous vehicles developed at Carnegie Mellon in
the 1980s (Kim & Calise, 1997), (Ali, 1994), (Pomerleau, 1989).
ANNs consist of artificial neurons - ‘cells’ that each accept weighted data points and
output values based on the function encoded in each cell. One of the first artificial neurons
7
Figure 2: ANN Architecture
is the perceptron, a cell that takes several binary inputs to produce a single binary output.
A simple example to demonstrate its use is in deciding whether to go to the beach. The
output decision y can have a value of either 1 (go to the beach) or 0 (stay at home). To
make this decision, the perceptron accepts inputs x1 (1 if the weather is sunny, 0 if it is
raining) and x2 (1 if you are alone, 0 if your friend accompanies you), and encodes their
relative importance in weights w1 and w2. The perceptron has a pre-defined function that
outputs a decision based on the inputs and weights. Suppose the weather is sunny but you
have no company, and the decision function is given by
y = w1x1 − w2x2
The ANN knows you love a sunny day more than anything; it has learnt w1=0.9 and w2=0.3,
the perceptron outputs a decision to go to the beach even if you don’t have company.
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2.4.1 Training
An ANN typically has multiple layers of neurons (Fig. 2). The leftmost layer accepts
input data; the rightmost layer outputs the decision. Between the two, there are a number
of hidden layers where most of the data crunching takes place. Each neuron has a weight
associated with it; they are initialized to a random value. Training an ANN involves feeding
it input data, allowing the hidden layers to process the inputs to output a decision, and
comparing it with the true (expected) decision. The difference in outcomes - “loss”- is then
reduced by modifying the weights in each of the neuron layers until the network has attained
a desired level of accuracy.
2.5 Deep Neural Networks
The advent of Big Data and faster computation has led to a newer paradigm in neural
networks called Deep Learning (DL). Deep Neural Networks (DNN) work in a different
fashion from ANNs. ANNs primarily learn a function that predicts the target from the input
data with minimal error. DNNs first engineer new simpler features that are representative
of the input, and then use these features to predict the target. This is achieved by tuning
each neuron to have a very simple non-linear function. The DNN learns complex concepts
by abstracting these simple representations. For example, it represents the concept of an
image by combining simpler concepts like contours and shading, which are in turn composed
of extremely simple representations like edges.
DNNs often have numerous hidden layers, which means more sequential operations on the
data. This allows them to execute tasks which are too complex for traditional ML algorithms,
such as detecting people and animals in images. Google Lens turns any smartphone camera
into an oracle; pointing the camera to an object displays information about it (along with
advertisements of where it can be purchased). Intelligent assistants like Alexa and Siri make
use of DL to comprehend speech and respond appropriately. The sequential operations helps
the model to retain “states” of information (similar to how humans process information
9
Figure 3: LSTM Cell
streams) and allows it to infer subtle differences and create representations of them.
Recurrent Neural Networks (RNN) are distinct from traditional feed-forward networks.
In a feed-forward network, hidden layers send their outputs only in one direction. RNNs
instead allow feedback within the hidden layers; the output of a neuron is not only sent to
subsequent hidden layers, but it also forms part of the input to itself after a preset delay.
There are two kinds of RNNs that are of interest in temporal EHR analysis - Long Short-
Term Memory (LSTM) and Gated Recurrent Units (GRU).
2.5.1 LSTM
LSTM (Fig. 3) is a special type of RNN whose hidden state architecture attempts to
emulate human information and memory processing (Gers, Schmidhuber, & Cummins, 1999).
LSTM units have cell-states that maintain information over the entire sequence (“long-term
memory”), and forget-gates that update the cell-state with every new piece of information the
network processes. With sufficient training, the network learns which pieces of information
are most important to the output, and “forgets” the others.
10
Figure 4: GRU Cell
2.5.2 GRU
GRU (Fig. 4) is similar to LSTM in functionality; it has 2 gates - the “reset” gate
which determines how much of the past should be considered, and the “update” gate which
determines the attention tradeoff between the current candidate-state and the previous state
(Cho, van Merrienboer, Bahdanau, & Bengio, 2014). GRU is computationally more efficient
than LSTM, and researchers usually evaluate both units’ performances on sequential mod-
elling tasks. This work uses a specialized extension of the GRU called the GRU-Decay (Che,
Purushotham, Cho, Sontag, & Liu, 2018).
2.6 Machine Learning in IBD Research
Researchers have used machine learning (ML) to further our understanding of IBD and to
guide clinical care. (Wei et al., 2013) predict the genetic risk of CD and UC in a genome-wide
11
association study using traditional ML models. (Yazdani et al., 2016) project to identify dif-
ferences in gut microbiomes of healthy and disease states heavily relied on the Random Forest
algorithm. (Mahapatra et al., 2013) segment CD-affected tissues in MRI scans using graph
cuts and Random Forest classifiers. (Mossotto et al., 2017) used a combination of supervised
and unsupervised learning on endoscopic and histological data; they used unsupervised meth-
ods to reduce dimensionality and obtain clusters identifying phenotypes (CD/UC) of IBD in
the data, and trained a SVM (support vector machine) classifier to predict the phenotype.
(Waljee et al., 2017) trained Random Forest models to forecast IBD-related hospitalizations
and steroid use based on aggregates of previous histories.
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3.0 Prior Work and Motivation
As part of a preliminary study, I trained various ML models to classify a patient as High-
Cost (<$100,000/year) or not, based on the same IBD patient registry dataset (Anderson
et al., 2016) used here. After cleaning and preprocessing, I created three representations
of the registry dataset. The first dataset maintained the data in their originally recorded
format (continuous values). In the second dataset, all numerical features were discretized into
categorical labels according to clinical guidelines. In the third dataset, created primarily for
training an ANN, each feature was represented as a set of binary dummy variables. Finally,
all the observations per patient were aggregated into a single entry. A suite of algorithms
- Gradient Boosted Trees, SVM, Tree-Augmented Networks, and a Feed Forward Neural
Network - were trained on these aggregated datasets to classify the patient into a utilization
phenotype. I obtained an accuracy of 0.89 and an AUROC of 0.748, with features relating
to lab results and clinician encounters being most indicative of future charges. To the best
of my knowledge, there is no system that models the sequential changes in an IBD patient’s
state to predict future IBD-related outcomes. One critical limitation of modelling aggregate
clinical data is that they do not take into account the temporal nature of patient treatment
trajectories. However, the classification results were strong enough to suggest support for
ML approaches to analyze IBD patients in this registry.
To better capture the intertemporal dynamics, the problem requires to be modelled as a
multivariate time series. The motivation to use RNNs comes from recent research applying
deep recurrent networks to sequential data in the clinical domain. These algorithms are
well-suited for large datasets with many features, and the typical size of clinical datasets in
the literature are in the order of several hundred thousand to over a few million observations
(Johnson et al., 2016) (Ho, Ledbetter, Aczon, & Wetzel, 2017). The dataset used in this
study is much smaller in comparison (218,000 observations), and this poses a different set of
challenges for effectively modelling the latent distribution in the samples without overfitting
to modal patterns. This work incorporates multitask learning that has its roots in clinical
prediction (Caruana, Baluja, & Mitchell, 1995).
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4.0 Data Description
This work uses a research registry of IBD patients collected at the University of Pitts-
burgh Medical Center (UPMC) tertiary care center for digestive disorders. The registry
contains datasets of timestamped clinical events such as pathological lab results, active drug
prescriptions, diagnostic and surgical procedures, encounters with care providers, Quality-of-
Life survey responses, and billing data. These events were merged into longitudinal sequences
with 53 dynamic variables for each patient. The sequences are resampled to a monthly rate
and the total measurements are recorded in each monthly window. To prevent confounding
the model, patients being treated for cancer and/or who had a transplant are excluded. This
results in a final population of 2390 patients who have treatment courses ranging from 32
months to 11 years. The data has an average sparsity of around 78%.
4.1 Features
This section presents the clinical features used as predictors to train the model.
4.1.1 Drug Prescriptions
The following categories of prescription drugs are commonly used in IBD treatment:
• 5-aminosalicylic acid (5-ASA)
• Systemic Steroids
• Immunomodulators
• TNF Inhibitors
• Antil-Interleukin-12 antibodies
• Anti-Integrin antibodies
• Vitamin D supplements, and
• Psychotherapeutic drugs
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Each class of drugs pertains to a specific need in the patient. Some drugs are prescribed
only in extenuating circumstances. Therefore, this data holds important information about
the physician’s estimate of the patient’s current state. The choice to include Psychiatric
drugs was made because IBD is known to affect patients’ well-being and quality of life, and
a number of studies have attempted (Cawthorpe, 2015) to estimate the relationship between
mental health and IBD.
Information about active prescriptions is encoded as a binary variable for each patient-
month.
4.1.2 Clinical Lab Results
A physician might prescribe specific lab tests if they suspect those values to be abnormal.
Typical lab tests conducted for an IBD patient are:
• 5-Eosinophils (EOS) (Click, Anderson, et al., 2017)
• Monocytes (Cherfane et al., 2016)
• Albumin (Koutroubakis, Regueiro, et al., 2016)
• Hemoglobin (Koutroubakis, Ramos-Rivers, et al., 2016)
• Erythrocyte Sedimentation Rate (ESR)
• C-Reactive Protein (CRP), and
• Vitamin D (Kabbani et al., 2016)
Different lab testing sites use non-standard units. To counter this hetereogeneity, each
lab is one-hot encoded for ‘Low’, ‘Normal’ or ‘High’ based on clinically-defined ranges,
and the results are summed up for each patient-month.
4.1.3 Diagnostic Procedures
The following gastrointestinal diagnostic tests were included in the dataset:
• Colonsocopies
• Endoscopies
• Sigmoidoscopies
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• Ileoscopies
• Anoscopies
• Abdomen/Pelvis CT Scans
The total number of each of these diagnostics in a patient-month is recorded.
4.1.4 Surgeries
The number and frequency of gastrointestinal (GI) surgical procedures is a strong clinical
predictor of disease severity (Limsrivilai et al., 2017). Prominent surgeries are colectomies,
resections, fistulas and abscesses. All GI surgeries are totaled in each patient-month.
4.1.5 Clinician Encounters
The number of encounters a patient has with their healthcare provider is important
information, especially if there is a sudden rise or dip in the frequency (Ramos–Rivers et
al., 2014). Encounters are grouped by the channels used - telephone, email or office visits.
Encounters at non-GI departments are retained in the dataset, but their counts are stored
in a separate variable.
4.1.6 Disease Descriptors
Although Crohn’s Disease and Ulcerative Colitis are collectively termed as IBD, both
conditions have differences in symptoms and treatment pathways. Instead of training a
separate model, I include a binary flag indicating the disease type. The Harvey Bradshaw
(HB) Questionnaire is a survey measuring IBD patients’ quality of life and well-being. More
than 2000 patients had at least one response ever. Clinical research suggest the HB Index is a
good approximator for disease severity. (Vermeire et al., 2010). Age of Diagnosis is included
as some studies suggest a difference in disease phenotype and natural history according to
the age of onset (Quezada, Steinberger, & Cross, 2012).
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4.1.7 Charges
Clinical researchers helped to identify billed procedures that were related to IBD. I
retained the unrelated procedures and their charges in a separate variable as a proxy for
the patient’s comorbidities. All charges were inflation-adjusted for 2018 (year of the last
observation).
4.2 Model Inputs
A patient’s input multivariate time series of length T having D variables is denoted by
Xp = [x
(1)
p , ..., x
(t)
p ] ∈ RT×D where x(t) ∈ RD refers to the observation at time-stamp t. X
is normalized to a standard scale of [-0.5, 0.5] to enable faster convergence in training. To
regularize the time series, X is resampled to a monthly rate. Doing so however heavily
increases sparsity, resulting in 78% of the values ”missing”.
4.2.1 Missingness Metadata
In addition to Xp, the model is fed two other vectors - the observed mask Mp =
[m
(1)
p , ...,m
(t)
p ] ∈ {0, 1}T×D denoting which variables are observed at time step t, and the
last seen interval ∆p = [δ
(1)
p , ..., δ
(t)
p ] ∈ RT×D denoting how long ago from time step t were
the variables last observed.
4.2.2 Patient Time Series
Given a patient’s history Hp over M months, a sliding window is used to obtain overlap-
ping training examples with a look-back period b and look-forward period f, such that the
i -th example pair (X(i), Y (i)) is given by (Hp,i:b+i,, Hp,b+i:f+i,). The target labels extracted
from Y (i) (for the period f) are:
• annualized total charges
• lab results
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• diagnostics tests conducted
• total surgeries conducted
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5.0 Methods
This work investigates if a deep network can learn to adequately represent a temporal se-
quence as a single vector. Casting this problem as a multi-class multi-label forecasting task —
given a patient’s time series data D = [X,M,∆], predict the labels Lcharge, Llab, Ldiag, Lsurg
— it is possible to test how much information about the future does this representation hold.
The proposed model consists of two major blocks - the RNN encoder, which derives an
abstract representation of the time series, and the classifiers which predict a label.
5.1 Cross Validation for Time Series
Cross-validation (CV) is a popular and important technique for identifying optimal hy-
perparameters and providing robust measurements of model performance. Two popular
cross-validation methods are k-fold and holdout cross-validation. For this study that involves
a small dataset of clinical time series, various data splitting schemes come with different
caveats (Bergmeir & Ben´ıtez, 2012) (Sherman, Gurm, Balis, Owens, & Wiens, 2017). The
following sections elaborate on the splitting methodologies and the constraints associated
with them.
5.1.1 Naive K-fold Split
In K-fold CV, the dataset is randomly split into K different test sets, and for each
set the model is trained on the remaining data. The model is then evaluated by sampling
performance scores from all K sets. Such a split ensures that the model is trained and tested
on samples that are most representative of the clinical time series.
A significant drawback of this is a risk of information leak between the train and test
sets. The random split does not take the chronology of events into consideration, and the
training set may contain later observations than the ones in the test set. As verified in this
19
work, this data leakage trains models that have excellent cross-validation and test scores,
but performs poorly on a holdout set of unseen patients.
5.1.2 Chronological Holdout
To overcome these integrity violations, the latter parts of each patient’s time series is
held out, and the model is trained only on the former observations. This upholds validation
integrity, but at the cost of informativeness. In the IBD time series, clinical events do not
follow a general monotonic trend that can be approximated by a model. Events of interest
like spikes in abnormal CRP levels or an intensive surgery can occur anywhere in the time
series. Given a sufficiently large sample, the model may better approximate the population
function from a chronologically-split training set, but it is more difficult to do so from a
small esoteric sample.
Moreover, for large look-back b and look-forward f periods, this technique reduces the
number of usable observations. Consider a patient whose total duration spans 60 months.
Assuming a training set size of 80%, the test size of this patient then contains 12 months.
It is not possible to generate test examples for any b + f > 12. To use this cross-validation
method, the b and f must be small enough to accommodate a representative test set, while
still being clinically useful. In the experiments, I use a chronologically held-out set of b = 24,
f = 8, and a training size of 60%
5.1.3 Chronological Split with Overlap
This scheme refers to a trade-off between the Naive Split that favours representativeness
over small data but allows information to leak, and the Chronological Holdout that upholds
validation integrity but cannot be used on small datasets. Here the chronological train-test
split is not conducted on the patients’ time series, but on the sliding window sequences
generated from the time series. There is a minor information leak here: some observations
will be a member of both the latter sequences in the training set, and the initial sequences
of the validation set. However this may be an acceptable compromise, as the training set is
not privy to the target labels in the validation set. Moreover the chronological overlap of
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the training and test set is much lesser (because of the intermediate validation set), allowing
an honest evaluation of the model in real-world scenarios. In the experiments, I use this
splitting scheme for b = 24 and f = 8, with a training size of 80% instead of 60%.
5.2 Model
5.2.1 Encoder
The encoder block of the model consists of L stacked GRU-D layers having 6D hidden
memory units each, where D is the number of input dimensions. In the following equations,
h
(t)
l represents the hidden state at layer l, and h
(t)
l−1 is the output of the previous layer at the
same time step (or x(t) if l = 0). h
(t−1)
l is the output of the same layer from the previous
time step (or a zero-vector when t = 1).
γ
(t)
l = exp{−max(0,Wlδ(t) + bγ)} (5.1)
x
(t)
decay = m
(t)  x(t) + (1−m(t)) (γ(t)x  x(t
′) + (1− γ(t)x ) x˜) (5.2)
xˆ
(t)
l = {
x
(t)
decay, if l = 1
h
(t)
l−1, if l > 1
(5.3)
hˆ
(t−1)
l = γ
(t)
h  h(t−1)l (5.4)
GRU-D decays the inputs to emulate homeostasis when it encounters missing values.
The cell learns vectors of decay rates γx and γh at each time step (Equation 5.1). At the
first layer, missing values in the input x(t) are replaced by a convex combination of the last
observed value x(t
′)(t′ < t) and the empirical mean x˜ for each variable. Inputs to subsequent
layers are not modified (Equations 5.2 - 5.3). The hidden state from the previous time
step h(t−1) is also decayed (the authors of the GRU-D paper suggest this captures richer
information of missingness directly into the encoded representation).
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The decayed input and hidden state are then used to compute the new hidden state h(t)
according to the standard GRU gates:
r(t) = σ(Wrxˆ
(t) + Urhˆ
(t−1) + Vrm(t) + br) (5.5)
z(t) = σ(Wzxˆ
(t) + Uzhˆ
(t−1) + Vzm(t) + bz) (5.6)
h˜(t) = tanh(Wxˆ(t) + U(r(t)  hˆ(t−1)) + V m(t) + b) (5.7)
h(t) = (1− z(t)) hˆ(t−1) + z(t)  h˜(t) (5.8)
The hidden state of the final layer h
(T )
L is the abstract representation that is used to
classify the input sequence.
5.2.2 Classifier
The model consists of 4 classifiers to predict the charges, diagnostics, lab results, and
surgeries in the look-forward period. Each classifier is made up of 3 fully-connected (FC) lay-
ers with a Leaky ReLU activation between them. To reduce the risk of vanishing/exploding
gradients and facilitate faster convergence, the network uses Xavier weight initialization.
5.2.2.1 Activation Functions Activation functions are typically non-linear and enable
the network to learn non-linear approximations of the data. Each FC layer is a linear trans-
form of its inputs; the result of stacking multiple linear layers is therefore simply another
single linear transform with different parameters. Non-linear activations interspersed be-
tween linear FC layers enable the model to generalize over comples phenomena.
The Rectified Linear Unit or ReLU y = max(0, a) is a non-linear activation function that
is applied to a neuron output a = W Tx + b. ReLU is popular in many deep networks for
its simplicity and effectiveness. The ReLU’s slope is always 0 for non-positive inputs, and 1
otherwise. While this appears to be a limited type of non-linearity, the combined activations
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across many neurons (and their various biases) enables the network to model highly complex
non-linearities in a computationally efficient manner.
ReLU is usually more robust to vanishing gradients than tanh and sigmoid activations.
However, in case all the neuron outputs are negative, the ReLU gradients will be zero and
training stagnates - giving rise to the ”dying ReLU” problem. Leaky ReLU solves for this
by allowing negative inputs to have a very small non-zero output, thus ensuring that the
neuron activation is always non-zero for non-zero inputs.
5.2.3 Regularization
A model with a large number of free parameters can fit to an exceedingly wide range
of phenomena. The architecture described above has well over a million! In the absence
of larger datasets, a large and eager model is apt to mistake noise or peculiarities as valid
signals.
Typical regularization methods in deep learning are weight decay and dropout. Weight
decay appends a term (usually the L1 or L2 norm) to the network’s loss function; this
reduces neuron weights in proportion to the network’s complexity and a training hyperpa-
rameter. Dropout is a more radical approach specific to neural networks, where the network
randomly and temporarily shuts down some of the neurons during training. Compensating
for their absence, the remaining neurons are ”forced to learn robust features that are useful
in conjuction with a random subset of neurons” (Krizhevsky, Sutskever, & Hinton, 2017).
There is no clear science to non-empirically determine the best regularization approach.
While it is possible to include both weight decay and dropout, the models in this work use
only dropout.
5.2.4 Multitask Learning
Each of the 4 classification tasks has an associated prediction loss that is backpropagated
through the model. The output of the classifiers is a logit, or the log of the probabilities for
each of the target classes.
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5.2.4.1 Charges Predicting the likely inpatient charges s to be incurred by a patient is
this model’s primary task. To simplify the task, it is treated as a classification problem by
discretizing the annualized charges as
ychg =

Low, if s
f
× 12 < $10, 000
Mid, if $10, 000 ≤ s
f
× 12 < $80, 000
High, if s
f
× 12 ≥ $80, 000
Figure 5: Histogram of annual charges
The boundaries for each of the classes was determined after consulting with clinicians
and observing the data (Figure 5). The C = 3 target classes are mutually exclusive with only
a single correct class c per example. The classifier’s logits are passed to a softmax function
to obtain the predicted probabilities yˆ for each class. The loss for the task is the categorical
cross-entropy loss averaged over N examples.
Lchg = − 1
N
∑
log
(
eyˆc∑C
j e
yj
)
24
5.2.4.2 Diagnostics, Labs, Surgeries Along with learning to predict charges, the
model also forecasts on these auxiliary tasks in a bid to learn well-rounded representa-
tions of the clinical time series. The training vector yaux ∈ {0, 1}15 indicates if either of
the 8 diagnostics, 6 labs or a surgery was conducted in the look-forward period. Since they
are not mutually exclusive, the logits for each of these are passed to a sigmoid function to
obtain their independent probabilities. The loss for is the average binary log loss over all N
examples.
Laux = − 1
N
∑
[yaux · log(yˆaux) + (1− yaux) · log(1− yˆaux)]
5.2.4.3 Replicated Targets This technique involves having the model make a predic-
tion about the charges at every intermediate step in the time series. Lipton et. al suggest
capturing local error signals to overcome the problem of backpropagating the error across
time. They also use linear scaling to increase the weights of errors made towards the end of
the time series. However it is not immediately clear if recent events in the IBD time series
are more predictive than earlier events. Hence errors at all steps are weighted equally, and
the loss is the average log loss over all T time steps.
Ltr = − 1
N
1
T
∑
N
∑
T
log
(
eyˆc∑C
j e
yj
)
Losses Lchg, Laux, and Ltr are combined by taking their weighted average:
L =
αchg · Lchg + αaux · Laux + αtr · Ltr
αchg + αaux + αtr
where α ∈ [0, 1] is a hyperparameter that determines the relative importance of each task’s
error.
5.3 Experiments
I attempt to investigate the ability of deep networks to model clinical time series data with
different architectures and dataset splits. The following sections elaborate on the variations
tested, the evaluation methodology and results.
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5.3.1 Time Horizons
The set of examples for a patient p with a total treatment duration N contains the
overlapping sequences with a look-back period of b months and look-forward period of f
months is given by:
Xp = {(H(0:b)p , y(b:f)chg|p), (H(1:b+1)p , y(b+1:f+1)chg|p ), ..., (H(N−b−f :N−f+1)p , y(N−f+1:N)chg|p )}
The values of b and f determine the number of overlapping examples obtainable from the
dataset. Smaller values result in a larger number of training samples — beneficial for training
models with adequate validation — but are unable to capture the long-term chronicity of
IBD. A reasonable midway was considered to be b = 24 and f = 8, which is used in the
experiments.
5.3.2 Multitask Loss
For an investigation into the multitask learning effects, the following variations are re-
ported:
1. No multitask learning (αaux = 0 and αtr = 0)
2. Auxiliary training without Target Replication (αaux = 0.5 and αtr = 0)
3. Target Replication without Auxiliary training (αaux = 0 and αtr = 0.5)
4. Complete multitask learning (αaux = 1 and αtr = 1)
Their effects are noted by comparing the training and validation losses during training. It
is expected that multitask learning will have an implicit regularizing effect.
5.3.3 Architectures
All the models trained in these experiments use 2 stacked GRU-D layers with 312 memory
units each, and 3 fully-connected layers. This model includes dropout with probability
p = 50% after each GRU-D layer and p = 30% after each fully-connected layer. It does
not use weight decay. A shallow network containing 1 GRU-D layer & 2 fully-connected
layers was unable to learn the data and was outperformed by the deep models as well as the
baselines.
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5.3.4 Baseline
Baselines are well-understood models that provide a point of reference for performance.
To provide a minimum baseline, I report the performance of logistic regression, which is
widely used in clinical research. A stronger baseline that is more closely related to the
deep network is a multilayer perceptron with 3 layers of 312 hidden units, Leaky ReLU
activation and 50% dropout. Hyperparameters are chosen from cross-validation, and the
MLP is trained for 100 epochs. Both baseline algorithms accept only fixed-size inputs,
therefore each sequential input is averaged into one observation before feeding to the baseline
classifier.
5.3.5 Evaluation Metrics
Commonly-used classification metrics like accuracy and Area Under the ROC Curve are
inadequate to explain a classifier’s performance on imbalanced datasets. The data used in
these experiments is extremely skewed; 87% of the samples have a label of Low. A base
rate classifier that makes random predictions according to this distribution would have an
accuracy of over 60%. A model that only predicts the majority class will obtain an accuracy
of 87% - high, but very misleading.
Since this DSS is intended for clinical use, it is important to consider the reliability of
the model’s predictions. A few metrics that measure these are Log Loss (lower is better),
Cohen’s Kappa (higher is better), Matthews Correlation Coefficient (higher is better), Brier
Loss (lower is better). Kappa is a coefficient of agreement; here it measures how much
better are the model’s predictions than a base rate classifier. A pitfall of the Kappa is
that it is dependent on how the probability of chance in the base rate is defined. A more
informative and less biased metric is the Matthews Correlation Coefficient (MCC) which
simply computes the correlation coeffecient between the true and predicted labels (Chicco
& Jurman, 2020). Therefore this value is high only when the model achieves good results in
all four confusion matrix categories. The possible values range from [−1, 1] and should be
interpreted similar to the correlation coeffecient.
Predicting High-Charge (HC) patients is of more interest (and difficulty); I report the
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Area Under the Precision-Recall Curve (AUPRC ) as a single-point estimate of ability to
predict sequences as HC. An ideal DSS should have high precision and recall but in the
real-world there is a tradeoff between the two. I report the observed recall at specific levels
of precision of 0.4 (R@P=0.4 ).
These metrics are useful to compare different models’ performances, but are insufficient
to evaluate a model in the real-world. A more fair comparison might involve clinical ex-
perts providing their predictions given only the data seen by the model. This is however
prohibitively expensive and the manual effort needed is difficult to justify.
5.4 Results
This section presents the evaluation results of 8 GRU-D models and 2 baseline Multi-
layer Perceptrons models. The 4 variations of multitask loss coefficients and both baselines
(described in Section 5.3.2) are trained and tested on the Chronological Holdout (HO) and
Chronological Overlap (OL) data splits. I don’t report results of the Logistic Regression
baseline as it only predicted the majority class for the entire test case.
Both baseline models bias their predictions to Low-Charge; Baseline-OL predicts 90%
of the 2,192 High-Charge sequences as Low-Charge. In comparison, the best performing
GRU-D-OL model (αaux = 1, αtr = 1) has a recall of 34% on the High-Charge patients, and
predicts another 32% as Mid-Charge (Appendix A) .
Among the GRU-D models, there is no clearly dominating performance in Table 5.4;
from the metrics, it is unclear how multitask learning and target replication are contributing
to model performance. However it must be noted that the GRU-D models are trained only
on 50 epochs for this experiment; these are probably not enough runs for the complex model
to fit all million of its parameters to the data.
Plotting the training and validation loss lends some insight into the regularization prop-
erties of multitask learning (Appendix B). For αtr > 0 the validation loss drops in tandem
with the training loss, and increasing αaux to 1 appears help the model converge faster.
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Model αaux αtr LogLoss Kappa MCC AUPRCHC R@P=0.4 Accuracy
Baseline-OL 0.442 0.101 0.200 0.272 0.221 0.872
GRU-D
on
OL
0 0 0.645 0.223 0.234 0.248 0.182 0.759
0 0.5 0.584 0.228 0.231 0.274 0.228 0.796
0.5 0 0.594 0.229 0.241 0.248 0.198 0.763
1 1 0.589 0.236 0.243 0.267 0.211 0.778
Baseline-HO 0.369 0.014 0.079 0.213 0.119 0.904
GRU-D
on
HO
0 0 0.672 0.154 0.179 0.222 0.203 0.733
0 0.5 0.814 0.099 0.136 0.174 0.119 0.606
0.5 0 1.010 0.094 0.144 0.250 0.222 0.542
1 1 0.806 0.141 0.180 0.268 0.241 0.677
Table 1: Experiment Results
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6.0 Conclusion
In this work, I have explored methods to make the IBD EHR data suitable for training
a DNN. The chronic nature of IBD means clinical events can occur irregularly in a patient’s
lifecycle. Typical approaches include aggregating past observations or hand-engineering fea-
tures describing some temporal characteristics. In consultation with clinical experts and
practitioners, I cleaned, processed and feature-engineered unstructured EHR data. I built
the data pipeline to transform the raw contents of the EHR database to inputs for a neural
network.
One hypothesis that I sought to explore in this work is if the irregularities in medical
histories hold useful information. I appended these inputs with metadata about its missing
variables, specifically about which ones were missing, and how long they have been missing
since. I implemented a specialized GRU-D cell to learn the missingness patterns from the
metadata, and built a neural architecture to learn a sequence of clinical events.
I trained the model to primarily predict the healthcare utilization, and on secondary
objectives of clinical importance, in an approach called multitask learning. I varied the
importances of the secondary objectives relative to the main task, and report their impact
on model performance. I reported the classification scorecard of each model, and a the
performance of a strong baseline classifier.
In the results I did not find conclusive evidence for multitask learning contributing to
well-rounded abstract representations; one reason for this could be that the models were
trained only for 50 epochs (models of this scale are usually trained for several hundred
epochs) and were not able to learn deeper patterns in the data yet. That said, it is clear
that models which learn to perform on multiple tasks simultaneously have a stable training
progress; performance on the validation set is similar to that on the training set. This makes
intuitive sense because the model tries to approximate an overall distribution instead of
latching on to a possibly spurious pattern that only exists in the training dataset. Future
experiments should have the model train for more epochs before testing.
Although quite complicated, the deep network makes relatively unbiased predictions on
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a highly imbalanced dataset, and performs better than the baseline on the metrics evaluat-
ing classification performance across minor and major classes. However, this performance
measure is relative to other classifier models, and may not absolutely capture the systemic
biases present in all the classifiers. More work needs to be done to test the clinical efficacy
of deep networks to IBD EHR analysis.
6.1 Future Work
More robust experimentation is required to conclusively confirm or dismiss the contribu-
tion of secondary tasks and replication targets to model efficacy. Not only is it important to
test the model over a larger number of epochs and varying look-back and look-forward time
frames, but it is also necessary to ensure that the data for the secondary tasks are pertinent
to the primary objective. In this work, the secondary tasks are to predict if a clinical event
occurred in the period in question or not. While this task is simple to engineer in the network
architecture, it might be too simplistic for the model to learn anything meaningful about the
current input sequence. Future work could consider including more nuanced tasks to allow
the model to learn aspects of the patient history clinicians might themselves look for, while
attempting a prognostication.
Clinician notes are a rich source of information that lays untapped in the IBD registry.
With the current advances in Natural Language Processing and Entity Recognition, these
notes could be a treasure for phenotyping a time slice of the patient’s treatment cycle.
Extracting meaningful features is an active area of research.
Lastly, future work in this direction will greatly benefit from augmenting the registry
dataset, with similar variables from a different population. Since response to IBD treatments
is widely variant across individuals, It is difficult to say if the registry dataset has enough
information to be representative of all patterns. The registry is maintained for patients in a
geographically co-located healthcare network, giving rise to the possibility of systemic biases.
Ideally, the augmented data should come from a demographic that is dissimilar to what we
currently have in the registry.
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Appendix A
Confusion Matrices

27708 0 56
2002 0 59
1955 0 237

Confusion Matrix for Baseline-OL

20395 0 1
769 0 3
1389 0 16

Confusion Matrix for Baseline-HO
Figure 6: Baseline Confusion Matrices

23657 2927 1180
1128 620 313
954 588 650

Confusion Matrix for GRUD-OL with
αaux = 1, αtr = 1

15799 2016 2581
401 154 217
580 225 600

Confusion Matrix for GRUD-HO with
αaux = 0, αtr = 0
Figure 7: GRUD Confusion Matrices
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Appendix B
Loss Trends During Training
Figure 8: Training and Validation Loss Trend (50 epochs) - OL Data Split
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Figure 9: Training and Validation Loss Trend (50 epochs) - HO Data Split
Loss trends are more stable with higher coefficients of secondary tasks.
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